Measuring inflammation in rheumatoid arthritis with a new clinical and ultrasound index: development and initial validation.


Journal

Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 29 04 2019
accepted: 15 07 2019
pubmed: 10 8 2019
medline: 2 6 2020
entrez: 10 8 2019
Statut: ppublish

Résumé

With the aim to develop and validate a clinical + ultrasound (US) inflammation score in rheumatoid arthritis (RA) for use in clinical practice, a mixed-method study was conducted. The theoretical development of the index was achieved with qualitative methodology (discussion group and Delphi survey). Subsequently, a cross-sectional study was carried out to analyse issues related to scoring and validation of the new index. RA patients underwent clinical [28 swollen and tender joints count, patient and physician global assessment (PhGA), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP)], and US assessments [synovitis or tenosynovitis by grey-scale (GS) and power Doppler (PD) of 42 structures]. An index was created based on statistical models and expert interaction. Construct validity was tested by correlation with DAS28, SDAI, CDAI, and PhGA. Reliability was evaluated in a subgroup of patients with the intraclass correlation coefficient (ICC). US assessment, CRP, and swollen joints were the items that passed the prioritization phase (Delphi study). For the cross-sectional study, 281 patients were randomly divided into design (n = 141) and validation samples (n = 140). The combination of US sites chosen (7 bilaterally) detected the maximum proportion of synovitis and PD present. Three scoring methods were tested: semiquantitative (0-3 GS + 0-3 PD), dichotomous (0/1 GS + 0/1 PD), and qualitative (0/1 based on algorithm). All showed strong correlation with activity measures (ρ ≥ 0.60), and reliability (ICC 0.89-0.93). The index with best parameters of validity, feasibility, and reliability was the qualitative. The final index chosen was the sum of swollen joint count, US qualitative score, and CRP. The UltraSound Activity score is a valid and reliable measure of inflammation in RA equal to the sum of 28 SJC, a simplified (0/1) US assessment of 11 structures and CRP. It is necessary further investigation to demonstrate additional value over existing indices.

Identifiants

pubmed: 31396686
doi: 10.1007/s00296-019-04383-9
pii: 10.1007/s00296-019-04383-9
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2137-2145

Subventions

Organisme : Societat Catalana de Reumatologia
ID : --

Références

J Rheumatol. 1993 Mar;20(3):579-81
pubmed: 8478878
J Thorac Dis. 2016 Aug;8(8):2146-57
pubmed: 27621871
Arthritis Care Res (Hoboken). 2012 May;64(5):675-82
pubmed: 22183834
Rheumatology (Oxford). 2003 Feb;42(2):244-57
pubmed: 12595618
Rheumatol Int. 2017 Aug;37(8):1347-1356
pubmed: 28389854
Ann Rheum Dis. 2016 Oct;75(10):1763-9
pubmed: 26590174
Ann Rheum Dis. 2013 Apr;72 Suppl 2:ii69-75
pubmed: 23253922
Ann Rheum Dis. 2007 Sep;66(9):1221-6
pubmed: 17369281
Rheumatology (Oxford). 2012 Jul;51(7):1246-60
pubmed: 22378717
J Rheumatol. 1993 Mar;20(3):543-5
pubmed: 8478868
Arthritis Rheum. 2008 Apr 15;59(4):515-22
pubmed: 18383408
Arthritis Rheum. 2001 Sep;44(9):2018-23
pubmed: 11592362
Ultraschall Med. 2012 Dec;33(7):E166-E172
pubmed: 21259184
Arthritis Res Ther. 2005;7(4):R796-806
pubmed: 15987481
Ann Rheum Dis. 1990 Nov;49(11):916-20
pubmed: 2256738
Rheumatology (Oxford). 2012 Jan;51(1):120-8
pubmed: 22072084
Ann Rheum Dis. 2007 Nov;66 Suppl 3:iii56-60
pubmed: 17934098
Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S100-8
pubmed: 16273793
J Coll Physicians Surg Pak. 2013 Jun;23(6):413-7
pubmed: 23763802
J Rheumatol. 2016 Nov;43(11):2010-2018
pubmed: 27803342
J Rheumatol. 2011 Sep;38(9):2055-62
pubmed: 21885517
Rheumatology (Oxford). 2014 Nov;53(11):2110-8
pubmed: 24929634
Mod Rheumatol. 2015 May;25(3):379-85
pubmed: 25401228
Rheumatology (Oxford). 2008 Apr;47(4):514-8
pubmed: 18321947
Scand J Rheumatol. 2011 May;40(3):178-82
pubmed: 21091275
RMD Open. 2016 Dec 16;2(2):e000325
pubmed: 28074154
Ann Rheum Dis. 2007 Mar;66(3):407-9
pubmed: 16926186
Ann Rheum Dis. 2013 Jul;72(7):1163-9
pubmed: 22956596
Rheumatology (Oxford). 2008 Apr;47(4):476-80
pubmed: 18281367
Ann Rheum Dis. 2010 May;69(5):828-33
pubmed: 19740905
Arthritis Rheum. 1995 Jan;38(1):44-8
pubmed: 7818570
Ann Rheum Dis. 2000 Nov;59 Suppl 1:i28-31
pubmed: 11053082
Rheumatology (Oxford). 2017 Aug 1;56(8):1320-1325
pubmed: 28431141
Arthritis Rheum. 2009 Sep 15;61(9):1194-201
pubmed: 19714611
Clin Exp Rheumatol. 2005 Nov-Dec;23(6):881-4
pubmed: 16396709
Semin Arthritis Rheum. 2018 Apr;47(5):619-629
pubmed: 29102157
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
J Rheumatol. 2007 Dec;34(12):2382-7
pubmed: 17985407
J Rheumatol. 2004 Jan;31(1):40-6
pubmed: 14705217
Arthritis Rheum. 1995 Nov;38(11):1568-80
pubmed: 7488277
Arthritis Rheum. 2007 Feb 15;57(1):116-24
pubmed: 17266071

Auteurs

Juan José de Agustín (JJ)

Servicio de Reumatología, Hospital Universitari Vall d´Hebron, Passeig de la Vall d'Hebron, 119-129, 08035, Barcelona, Spain. jjagor@hotmail.com.

Alba Erra (A)

Hospital Sant Rafael, Barcelona, Spain.

Andrés Ponce (A)

Hospital de Granollers, Granollers, Spain.

Carmen Moragues (C)

Hospital Plató, Barcelona, Spain.
Hospital Sant Pau, Barcelona, Spain.

Cesar Díaz-Torné (C)

Hospital Sant Pau, Barcelona, Spain.

Delia Reina (D)

Hospital Moisés Broggi, Sant Joan Despí, Spain.

Estefanía Moreno (E)

Hospital Comarcal de l'Alt Penedès, Vilafranca, Spain.

Julio Ramírez (J)

Hospital Clinic, Barcelona, Spain.

Lourdes Mateo (L)

Hospital Germans Trias i Pujol, Badalona, Spain.

Manel Pujol Busquets (M)

Hospital Universitari Mútua Terrassa, Terrassa, Spain.

Patricia Moya (P)

Hospital Sant Pau, Barcelona, Spain.

Pilar Santo-Panero (P)

Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain.

Sergi Ros-Expósito (S)

Hospital de Viladecans, Viladecans, Spain.

Javier Narváez (J)

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain.

Raimon Sanmartí (R)

Hospital Clinic, Barcelona, Spain.

Mª Jesús García de Yébenes (MJ)

Instituto de Salud Musculoesquelética (InMusc), Madrid, Spain.

Loreto Carmona (L)

Instituto de Salud Musculoesquelética (InMusc), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH